Search
for
Sort by
Research 181–210 of 1000+
- Pannexin 3 regulates skin development via Epiprofin
- Mesenchymal Stem Cells and Stromal Vascular Fraction for Hair Loss
- Rejuvenation of the Male Brow
- Psoriatic onychopachydermoperiostitis: improvement with etanercept
- Hair loss in children.
- The Effect of Stromal Vascular Fraction for Patients with Androgenetic Alopecia
- VASCULAR COMPLICATION AFTER LATERAL TEMPORAL LIFTING TECHNIQUE: A CASE REPORT
- Fibrosing Alopecia in a Pattern Distribution
- Answer of Regenerative Therapy Not Hair Treatment Patients with Androgenetic Alopecia Approved for Hairmetrix® Technology - Case Report
- The Role of injectable platelet-rich fibrin(i-PRF) and Advanced platelet-rich fibrin(A-PRF) in Androgenetic Alopecia: A New Frontier in Hair Regeneration
- Research Progress on the Application of Stem Cells in Hair Regeneration
- Dermatological history and examination
- The Biology of Hair Follicles
- Treatment of Hair Loss
- Dermal papilla cell number specifies hair size, shape and cycling and its reduction causes follicular decline
- Estrogens and the skin
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- 9 Role of 5α-reductase in health and disease
- Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Emerging nonmetabolic functions of skin fat
- Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations
- Anagen effluvium
- Female Pattern Hair Loss
- A Mouse Model of Androgenetic Alopecia
- Drug-Induced Hair Disorders
- Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia
- Combination of herbal extracts and platelet-rich plasma induced dermal papilla cell proliferation: involvement of ERK and Akt pathways
- Virilizing Adrenocortical Oncocytoma in a Child: A Case Report
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients